In T2DM, insulin signaling is disrupted in skeletal muscle, with increased serine phosphorylation of insulin receptor substrate 1 (IRS1), decreased AKT phosphorylation, and reduced translocation of the glucose transporter GLUT4 to the sarcolemmal membrane, thus impairing glucose uptake [3]. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.